(no title)
Smileyferret | 2 months ago
Also agree that using a PD-L1 mab feels like it’s for show especially considering the cancer model they’re using (Colon-26) was shown to be substantially less responsive to PD-L1 inhibitors…
Not the world’s best paper imo
nine_k|2 months ago
As they say, "the fame of a mathematician is measured by the number of poor papers", because pioneering works are often awkward, treading completely unknown ground. Maybe the same applies to biology sometimes?
snarf21|2 months ago
somedude89897|2 months ago
anotherpaul|2 months ago